SAREPTA THERAPEUTICS INC COM USD0.0001SAREPTA THERAPEUTICS INC COM USD0.0001SAREPTA THERAPEUTICS INC COM USD0.0001

SAREPTA THERAPEUTICS INC COM USD0.0001

No trades
See on Supercharts

Price target

185.200.000.00%
The 20 analysts offering 1 year price forecasts for 0L35 have a max estimate of — and a min estimate of —.

Analyst rating

Based on 22 analysts giving stock ratings to 0L35 in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


0L35 EPS for the last quarter is 0.34 USD despite the estimation of −0.06 USD. In the next quarter EPS is expected to reach 1.54 USD. Track more of SAREPTA THERAPEUTICS INC COM USD0.0001 financials and stay on top of what is up with the company.
In the next quarter SAREPTA THERAPEUTICS INC COM USD0.0001 revenue is expected to reach ‪589.45 M‬ USD. Check out SAREPTA THERAPEUTICS INC COM USD0.0001 revenue and earnings and make informed decisions.
According to analysts, 0L35 price target is 185.20 USD with a max estimate of 219.00 USD and a min estimate of 75.00 USD. Check if this forecast comes true in a year, meanwhile watch SAREPTA THERAPEUTICS INC COM USD0.0001 stock price chart and keep track of the current situation with 0L35 news and stock market news.
We've gathered opinions of 22 analysts rating 0L35 stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.